EP4110291A1 - PHARMACEUTICAL COMPOSITIONS COMPRISING 2-[(4S-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLIN-4-YL]ACETATE AND SODIUM IONS